Community Exposure to Perfluorooctanoate: Relationships Between Serum Levels and Certain Health Parameters

Objective: The objective of this study was to determine whether certain biomarkers of toxicity and/or a past diagnosis of liver or thyroid disease were associated with serum perfluorooctanoate concentrations (PFOA) in a community with longstanding environmental exposure to PFOA. Methods: Serum (PFOA), hematologic and biochemical biomarkers, and a questionnaire were administered to 371 residents selected by stratified random sampling and a lottery among volunteers. Median PFOA was 354 ng/mL (interquartile range, 181–571 ng/mL). Results: No significant positive relationships between serum (PFOA) and liver or renal function tests, cholesterol, thyroid-stimulating hormone, or with red cell indices, white cell, or platelet counts. Mean serum (PFOA) was not increased in those with a history of liver or thyroid disease. Conclusions: No toxicity from PFOA was demonstrated using the measured end points; other end points need to be addressed.

[1]  M E Hurtt,et al.  Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  Timothy R. Church,et al.  Quantitative Evaluation of Perfluorooctanesulfonate (PFOS) and Other Fluorochemicals in the Serum of Children , 2004 .

[3]  M Roberfroid,et al.  The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator. , 1991, Toxicology and applied pharmacology.

[4]  Paul D. Jones,et al.  Accumulation of perfluorooctane sulfonate in marine mammals. , 2001, Environmental science & technology.

[5]  M. Roberfroid,et al.  Peroxisomal Enzymes and 8-Hydroxydeoxyguanosine in Rat Liver Treated with Perfluorooctanoic Acid , 2004, Disease markers.

[6]  Yoichi Kawashima,et al.  Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. , 2003, The Journal of toxicological sciences.

[7]  F D Griffith,et al.  Animal toxicity studies with ammonium perfluorooctanoate. , 1980, American Industrial Hygiene Association journal.

[8]  J P Vanden Heuvel,et al.  Renal excretion of perfluorooctanoic acid in male rats: inhibitory effect of testosterone. , 1992, Journal of biochemical toxicology.

[9]  R H Ophaug,et al.  Metabolic Handling of Perfluorooctanoic Acid in Rats , 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[10]  H Hanhijärvi,et al.  Stimulation by oestradiol of the urinary excretion of perfluorooctanoic acid in the male rat. , 1989, Pharmacology & toxicology.

[11]  G P Daston,et al.  Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans. , 1997, Reproductive toxicology.

[12]  Pekka Peura,et al.  Disposition of perfluorooctanoic acid in the rat after single and subchronic administration , 1990, Bulletin of environmental contamination and toxicology.

[13]  F. Gilliland,et al.  Mortality among employees of a perfluorooctanoic acid production plant. , 1993, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[14]  J. Mandel,et al.  PLASMA CHOLECYSTOKININ AND HEPATIC ENZYMES, CHOLESTEROL AND LIPOPROTEINS IN AMMONIUM PERFLUOROOCTANOATE PRODUCTION WORKERS , 2000, Drug and chemical toxicology.

[15]  M E Hurtt,et al.  Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism. , 1992, Toxicology and applied pharmacology.

[16]  G. Kennedy,et al.  Dermal toxicity of ammonium perfluorooctanoate. , 1985, Toxicology and applied pharmacology.

[17]  R. E. Staples,et al.  The embryo-fetal toxicity and teratogenic potential of ammonium perfluorooctanoate (APFO) in the rat. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[18]  G. Kennedy,et al.  Inhalation toxicity of ammonium perfluorooctanoate. , 1986, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  Linda S. Birnbaum,et al.  Enhanced potential for oxidative stress in livers of senescent rats by the peroxisome proliferator-activated receptor alpha agonist perfluorooctanoic acid , 2004, Mechanisms of Ageing and Development.

[20]  N. Kudo,et al.  Sex hormone-regulated renal transport of perfluorooctanoic acid. , 2002, Chemico-biological interactions.

[21]  Jeffrey H Mandel,et al.  Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. , 2004, Chemosphere.

[22]  B. Taylor,et al.  Central administration of perfluorooctanoic acid inhibits cutaneous inflammation , 2005, Inflammation Research.

[23]  J. Depierre,et al.  Effects of peroxisome proliferators on the thymus and spleen of mice , 2000, Clinical and experimental immunology.

[24]  Jeffrey H Mandel,et al.  Epidemiologic Assessment of Worker Serum Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) Concentrations and Medical Surveillance Examinations , 2003, Journal of occupational and environmental medicine.

[25]  L. Buxton,et al.  Determination of perfluorooctanoic acid (PFOA) extractable from the surface of commercial cookware under simulated cooking conditions by LC/MS/MS. , 2005, The Analyst.

[26]  Roger G Perkins,et al.  The Toxicology of Perfluorooctanoate , 2004, Critical reviews in toxicology.

[27]  Qian Yang,et al.  Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. , 2002, Biochemical pharmacology.

[28]  F. Gilliland,et al.  An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. , 1998, Journal of occupational and environmental medicine.

[29]  B H Alexander,et al.  Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility , 2003, Occupational and environmental medicine.

[30]  Gerald L Kennedy,et al.  The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. , 2004, Toxicology.

[31]  J. V. Vanden Heuvel,et al.  Covalent binding of perfluorinated fatty acids to proteins in the plasma, liver and testes of rats. , 1992, Chemico-biological interactions.

[32]  Bogdan Szostek,et al.  Quantitative determination of perfluorooctanoic acid in serum and plasma by liquid chromatography tandem mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[33]  G. W. Jepson,et al.  Binding of perfluorooctanoic acid to rat and human plasma proteins. , 2003, Chemical research in toxicology.

[34]  C. Elcombe,et al.  Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  J. Johnson,et al.  Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[36]  Xiaofeng Yao,et al.  Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid. , 2005, Mutation research.

[37]  J. V. Vanden Heuvel,et al.  Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. , 1991, Journal of biochemical toxicology.

[38]  F. Gilliland,et al.  Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: a study of occupationally exposed men. , 1996, American journal of industrial medicine.

[39]  G. Gribble.  Naturally Occurring Organofluorines , 2002 .

[40]  Jeffrey H Mandel,et al.  Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. , 2003, Environmental health perspectives.

[41]  P. Hinderliter,et al.  Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[42]  B Beije,et al.  On the mechanism of the hepatocarcinogenicity of peroxisome proliferators. , 1991, Chemico-biological interactions.

[43]  Kouji Harada,et al.  Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. , 2005, Environmental research.